<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35957651</PMID><DateRevised><Year>2022</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2374-3735</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Journal of patient experience</Title><ISOAbbreviation>J Patient Exp</ISOAbbreviation></Journal><ArticleTitle>Prevalence of Long COVID-19 and its Impact on Quality of Life Among Outpatients With Mild COVID-19 Disease at Tertiary Care Center in North India.</ArticleTitle><Pagination><StartPage>23743735221117358</StartPage><MedlinePgn>23743735221117358</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23743735221117358</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/23743735221117358</ELocationID><Abstract><AbstractText>Literature is lacking on the spectrum of symptoms of long COVID-19 (defined as symptoms persisting beyond 28 days of diagnosis) and its impact on quality of life. This single-center, cross-sectional study included mild COVID-19 cases as determined by a positive real-time reverse transcription polymerase chain reaction test. Patients were contacted at least 28 days after diagnosis and were interviewed telephonically using semi-structured questionnaires for duration of symptoms, fatigue using Fatigue Severity Scale (FSS) and quality of life using the World Health Organization Quality of Life: Brief Version (WHOQOL-BREF). A total of 251 COVID-19 patients were included; of which 169 (67.3%) were males. The mean age of the patients was 35.8 years (SD&#x2009;=&#x2009;12.5). The prevalence of long COVID-19 was 28.2% (n&#x2009;=&#x2009;71, 95% CI: 23.0-34.2). The most common symptoms involved the musculoskeletal system (12.7%), upper respiratory tract (7.6%), and fatigue among 17 (6.8%) patients. Patients with long COVID-19 had significantly higher FSS score and lower WHOQOL-BREF score compared to the patients without long COVID-19 (&lt;28 days).</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sarda</LastName><ForeName>Radhika</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4760-797X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.</Affiliation><Identifier Source="RINGGOLD">28730</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Arvind</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.</Affiliation><Identifier Source="RINGGOLD">28730</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandra</LastName><ForeName>Ankit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, All India Institute of Medical Sciences, New Delhi, India.</Affiliation><Identifier Source="RINGGOLD">28730</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bir</LastName><ForeName>Megha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physiology, All India Institute of Medical Sciences, New Delhi, India.</Affiliation><Identifier Source="RINGGOLD">28730</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sanchit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.</Affiliation><Identifier Source="RINGGOLD">28730</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soneja</LastName><ForeName>Manish</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.</Affiliation><Identifier Source="RINGGOLD">28730</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>Sanjeev</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.</Affiliation><Identifier Source="RINGGOLD">28730</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wig</LastName><ForeName>Naveet</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.</Affiliation><Identifier Source="RINGGOLD">28730</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Patient Exp</MedlineTA><NlmUniqueID>101688338</NlmUniqueID><ISSNLinking>2374-3735</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">prolonged</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword><Keyword MajorTopicYN="N">sequelae</Keyword></KeywordList><CoiStatement>Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>2</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35957651</ArticleId><ArticleId IdType="pmc">PMC9358596</ArticleId><ArticleId IdType="doi">10.1177/23743735221117358</ArticleId><ArticleId IdType="pii">10.1177_23743735221117358</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Director-General&#x2019;s opening remarks at the media briefing on COVID-19-11 March 2020 [Internet]. [cited 2020 Sep 23]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.</Citation></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239-42.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, et al. Epidemiology of COVID&#x2013;19: a systematic review and meta&#x2013;analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93(3):1449-58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436673</ArticleId><ArticleId IdType="pubmed">32790106</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. 2020 [cited 2020 Sep 10]. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.</Citation></Reference><Reference><Citation>Centre for Disease Control and Prevention (CDC). Interim Guidance on Duration of Isolation and Precautions for Adults with COVID-19 [Internet]. 2020 [cited 2020 Sep 10]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html.</Citation></Reference><Reference><Citation>Ministry of Health and Family welfare. Revised guidelines for Home Isolation of very mild or presymptomatic COVID19 cases [Internet]. [cited 2020 Sep 25]. Available from: https://www.mohfw.gov.in/pdf/RevisedguidelinesforHomeIsolationofverymildpresymptomaticCOVID19cases10May2020.pdf.</Citation></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; United States, March&#x2013;June 2020. Morb Mortal Wkly Rep. 2020;69(30):993-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013-22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022 April 16. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>National Comprehensive Guidelines for Management of Post Covid Sequelae. [cited 2021 Dec 27]. Available from: https://www.mohfw.gov.in/pdf/NationalComprehensiveGuidelinesfor
ManagementofPostCovidSequelae.pdf.</Citation></Reference><Reference><Citation>World Health Organization. ICD-10 : international statistical classification of diseases and related health problems : tenth revision. World Health Organization; 2004. Accessed March 26, 2022. https://apps.who.int/iris/handle/10665/42980.</Citation></Reference><Reference><Citation>Samlani Z, Lemfadli Y, Errami AA, Oubaha S, Krati K. The Impact of the COVID-19 Pandemic on Quality of Life and Well-Being in Morocco. 2020 Jun 24 [cited 2020 Sep 8]; Available from: https://www.preprints.org/manuscript/202006.0287/v1.</Citation></Reference><Reference><Citation>Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun. 2020 Oct;89:531-42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260522</ArticleId><ArticleId IdType="pubmed">32485289</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008;31(11):1601-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2579971</ArticleId><ArticleId IdType="pubmed">19014080</ArticleId></ArticleIdList></Reference><Reference><Citation>The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9626712</ArticleId></ArticleIdList></Reference><Reference><Citation>Veeri RB, Gupta AK, Pal B, Siddiqui NA, Priya D, Das P, et al. Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis. Health Qual Life Outcomes. 2019;17(1):53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6437940</ArticleId><ArticleId IdType="pubmed">30922346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathvik BS, Parthasarathi G, Narahari MG, Gurudev KC. An assessment of the quality of life in hemodialysis patients using the WHOQOL-BREF questionnaire. Indian J Nephrol. 2008;18(4):141-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2813538</ArticleId><ArticleId IdType="pubmed">20142925</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. 2000.</Citation></Reference><Reference><Citation>Lapostolle F, Schneider E, Vianu I, Dollet G, Roche B, Berdah J, et al. Clinical features of 1487 COVID-19 patients with outpatient management in the greater Paris: the COVID-call study. Intern Emerg Med. 2020;Aug;15(5):813-17. 10.1007/s11739-020-02379-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02379-z</ArticleId><ArticleId IdType="pmc">PMC7260461</ArticleId><ArticleId IdType="pubmed">32474850</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. Clinical and epidemiological characteristics of 1,420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335-44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267446</ArticleId><ArticleId IdType="pubmed">32352202</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80(6):656-65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151416</ArticleId><ArticleId IdType="pubmed">32283155</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansey CM, Louie M, Loeb M, Gold WL, Muller MP, de Jager J, et al. One-Year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007;167(12):1312-20.</Citation><ArticleIdList><ArticleId IdType="pubmed">17592106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MHB, Wing YK, Yu MWM, Leung CM, Ma RCW, Kong APS, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson HW, Amo-Addae M, Kenu E, Ilesanmi OS, Ameme DK, Sackey SO. Post-Ebola syndrome among ebola virus disease survivors in montserrado county, Liberia 2016. BioMed Res Int. 2018(Oct;2018):8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6046154</ArticleId><ArticleId IdType="pubmed">30050920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epid&#xe9;mies &#xe0; Kikwit. J Infect Dis. 1999;179(Suppl 1):S28-35.</Citation><ArticleIdList><ArticleId IdType="pubmed">9988162</ArticleId></ArticleIdList></Reference><Reference><Citation>Cope H, David A, Pelosi A, Mann A. Predictors of chronic &#x201c;postviral&#x201d; fatigue. Lancet Lond Engl. 1994;344(8926):864-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7916407</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Xu H, Jiang H, Wang L, Lu C, Wei X, et al. The clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM Int J Med. 2020;113(9):657-65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313792</ArticleId><ArticleId IdType="pubmed">32442308</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021 Mar;82(3):378-383. 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med. 2020;52(5):1-1.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>